BELLUS Health Inc. (NASDAQ:BLU) went down by -3.49% from its latest closing price compared to the recent 1-year high of $7.65. The company’s stock price has collected -5.37% of loss in the last five trading sessions. Press Release reported on 11/10/21 that BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
Is It Worth Investing in BELLUS Health Inc. (NASDAQ :BLU) Right Now?
Plus, the 36-month beta value for BLU is at -0.05. Opinions of the stock are interesting as 9 analysts out of 9 who provided ratings for BELLUS Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $11.34. BLU currently public float of 70.96M and currently shorts hold a 4.26% ratio of that float. Today, the average trading volume of BLU was 2.41M shares.
BLU’s Market Performance
BLU stocks went down by -5.37% for the week, with a monthly drop of -8.36% and a quarterly performance of 63.66%, while its annual performance rate touched 96.95%. The volatility ratio for the week stands at 6.69% while the volatility levels for the past 30 days are set at 6.45% for BELLUS Health Inc.. The simple moving average for the period of the last 20 days is -14.07% for BLU stocks with a simple moving average of 33.95% for the last 200 days.
Analysts’ Opinion of BLU
Many brokerage firms have already submitted their reports for BLU stocks, with BTIG Research repeating the rating for BLU by listing it as a “Buy.” The predicted price for BLU in the upcoming period, according to BTIG Research is $9 based on the research report published on July 29th of the current year 2021.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see BLU reach a price target of $8. The rating they have provided for BLU stocks is “Outperform” according to the report published on January 29th, 2021.
Evercore ISI gave a rating of “Outperform” to BLU, setting the target price at $12 in the report published on November 18th of the previous year.
BLU Trading at -8.65% from the 50-Day Moving Average
After a stumble in the market that brought BLU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.05% of loss for the given period.
Volatility was left at 6.45%, however, over the last 30 days, the volatility rate increased by 6.69%, as shares sank -14.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.35% upper at present.
During the last 5 trading sessions, BLU fell by -5.37%, which changed the moving average for the period of 200-days by +52.49% in comparison to the 20-day moving average, which settled at $6.71. In addition, BELLUS Health Inc. saw 89.87% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for BLU
Equity return is now at value -51.90, with -48.00 for asset returns.